Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
Ana Lleò(Humanitas University), Massimo Colombo(University of Milan), Vincenza Calvaruso(University of Palermo), Maria Rendina, Andrea Aglitti(University of Salerno), V. Boccaccio(Humanitas University), Marcello Persico(University of Salerno), V. Di Marco(University of Palermo), Alessio Aghemo, Erica Villa(University of Modena and Reggio Emilia), Alessia Ciancio(Department of Medical Sciences), Alessia Giorgini(Università Cattolica del Sacro Cuore), Pietro Andreoné, B. Coco(Azienda Ospedaliera Universitaria Pisana), Maurizia Rossana Brunetto(University of Pisa), Luca Marzi(Azienda Ospedaliero-Universitaria di Modena), Elisabetta Degasperi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Massimo Zuin(AOL (United States)), S. Bollani(Azienda Ospedaliera Fatebenefratelli e Oftalmico), Savino Bruno(Humanitas University), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alfredo Di Leo(University Gastroenterology), Giulia Troshina(University of Turin), Patrick Maisonneuve(European Institute of Oncology)
Cited by 63
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
|JNCI Journal of the National Cancer Institute|1997|986
Development and Validation of a Food Frequency Questionnaire in Spain
|International Journal of Epidemiology|1993|933